175 related articles for article (PubMed ID: 1585282)
1. The theophylline dilemma.
Vadász I
Ther Hung; 1992; 40(1):3-7. PubMed ID: 1585282
[TBL] [Abstract][Full Text] [Related]
2. [Bamifylline in the therapy of asthmatic syndromes. Efficacy and side effects vs delayed-action theophylline anhydride].
Alciato P; Cantone PA; Fico D; Gagliardini R; Petrella V
Minerva Med; 1990; 81(1-2):93-7. PubMed ID: 2314621
[TBL] [Abstract][Full Text] [Related]
3. [Effect of slow-release theophylline on airway inflammation in bronchial asthma].
Adachi M; Minoguchi K; Mita S; Kokubu F; Suzuki H; Sano Y; Akiyama K; Yasuhara H
Arerugi; 1998 Aug; 47(8):734-43. PubMed ID: 9796114
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic and toxic theophylline levels in asthma attacks--is there a need for additional theophylline?].
Zeidman A; Gardyn J; Fradin Z; Fink G; Mittelman M
Harefuah; 1997 Jul; 133(1-2):3-5, 80. PubMed ID: 9332046
[TBL] [Abstract][Full Text] [Related]
5. [Theopek in the treatment of patients with obstructive diseases of the respiratory organs].
Korzh OB; Vygovskiĭ VP; Stadnicheko RA; Borzhievskaia OE; Kopel'man EI; Kozak KM; Senyk RV; Vygovskiĭ IaV
Vrach Delo; 1990 Jan; (1):41-2. PubMed ID: 2330707
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a short course of prednisolone with sustained-release theophylline in the control of nocturnal asthma.
Chhabra SK
Indian J Chest Dis Allied Sci; 1995; 37(1):7-14. PubMed ID: 16892732
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy of theopek in bronchial asthma and chronic bronchitis].
Korzh OB
Ter Arkh; 1990; 62(3):82-4. PubMed ID: 2368005
[TBL] [Abstract][Full Text] [Related]
8. [Inhalation therapy for bronchial asthma. A. Bronchodilator--beta 2-stimulant].
Takagi K; Yamaki K; Satake T; Awaya M
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Nov; 28(11):1405-9. PubMed ID: 2290222
[TBL] [Abstract][Full Text] [Related]
9. Theophylline in serum and in bronchoalveolar lavage (BAL) in atopic bronchial asthma and chronic bronchitis.
Plusa T; Józefczak E; Raczka A
Allergol Immunopathol (Madr); 1989; 17(1):29-32. PubMed ID: 2750638
[TBL] [Abstract][Full Text] [Related]
10. Combined theophylline/beta-agonists maintenance therapy in chronic asthma.
Eriksson NE; Haglind K; Ewald U
Eur J Respir Dis; 1983 Apr; 64(3):172-7. PubMed ID: 6132832
[TBL] [Abstract][Full Text] [Related]
11. [Prednisolone-dependent asthma patients--often under-treated in ambulatory care? Results of a retrospective study].
Förster R
Z Erkr Atmungsorgane; 1991; 177(1-2):96-102. PubMed ID: 1808860
[TBL] [Abstract][Full Text] [Related]
12. The effect of sustained-release theophylline in nocturnal asthma.
Freeman W; Packe GE; Cayton RM
Br J Clin Pract; 1991; 45(1):21-5. PubMed ID: 1931534
[TBL] [Abstract][Full Text] [Related]
13. Long-term oral therapy of asthma with terbutaline and theophylline, alone and combined.
Laursen LC; Taudorf E; Gnosspelius Y; Gymose E; Weeke B
Eur J Respir Dis; 1985 Feb; 66(2):82-90. PubMed ID: 2578971
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (Theograd, 350 mg Theolair Retard, and 300 mg Theolin Retard) in steady state in six normals and six patients with chronic asthmatic bronchitis--Part II: Lung function.
van der Vet AP; Kreukniet J; Drost RH; Maes RA
Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):339-44. PubMed ID: 4030161
[TBL] [Abstract][Full Text] [Related]
15. A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD.
Makino S; Adachi M; Ohta K; Kihara N; Nakajima S; Nishima S; Fukuda T; Miyamoto T; ;
Allergol Int; 2006 Dec; 55(4):395-402. PubMed ID: 17130682
[TBL] [Abstract][Full Text] [Related]
16. Controversies in asthma therapy with theophylline and the beta 2-adrenergic agonists.
Kelly HW
Clin Pharm; 1984; 3(4):386-95. PubMed ID: 6147224
[TBL] [Abstract][Full Text] [Related]
17. Lung function improvement, tremor measurements and c-AMP determinations in a group of ten patients with asthmatic bronchitis after one week sustained release theophylline medication (theophylline plasma level +/- 10 mg/l) compared to one week placebo.
Van der Vet AP; Kreukniet J; Drost RH; Maes RA; Fokkens JK; Hamelink ML
Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):638-42. PubMed ID: 3025113
[TBL] [Abstract][Full Text] [Related]
18. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
Pollert I
Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500
[No Abstract] [Full Text] [Related]
19. [The clinical application of long-acting preparations of theophylline].
Tanaka K
Nihon Rinsho; 1996 Nov; 54(11):3108-12. PubMed ID: 8950963
[TBL] [Abstract][Full Text] [Related]
20. Improved efficacy and safety of theophylline in the control of airways hyperreactivity.
Hendeles L; Weinberger M
Ann Allergy; 1982 Nov; 49(5):247-56. PubMed ID: 6128950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
